ADVISORY: Cummings to Testify Before Senate Commerce Committee About Investigative Report on “Gray Market” Drug Companies

Jul 20, 2012
Press Release

Washington, DC  – On Wednesday, July 25, 2012, Rep. Elijah E. Cummings, Ranking Member of the House Committee, will testify before the Senate Committee on Commerce, Science, and Transportation about a joint report on “gray market” drug companies as part of a bicameral investigation led by Cummings, Senator Rockefeller, Chairman of the Senate Commerce Committee, and Senator Harkin, Chairman of the Senate Health, Education, Labor, and Pensions Committee.

Cummings launched the investigation nearly a year ago after receiving a letter from University of Maryland women’s basketball coach Brenda Frese, who was having difficulty obtaining medication on the FDA’s shortage list to treat her son’s leukemia.

WHO:  Rep. Elijah E. Cummings

WHAT:  Testimony at Hearing on “Short-Supply Prescription Drugs:  Shining a Light on the Gray Market”

WHEN:  2:30 p.m. on Wednesday, July 25, 2012

WHERE:  Room 253, Russell Senate Office Building

The hearing will be webcast live via the Senate Commerce Committee website


112th Congress